Absolute Bioavailability and Nasopharyngeal Absorption of Intranasal Ketamine

A Randomized, Open Label, Single Center, Single-Dose, Cross-Over Study to Determine the Absolute Bioavailability and the Nasopharyngeal Absorption of PMI-150 (Intranasal Ketamine) in Healthy Adult Volunteers

This is an open label, single-center study to determine the absolute bioavailability and nasopharyngeal absorption of PMI-150 (intranasal ketamine) 30 mg in healthy adult volunteers.

To examine the safety and assess the absolute bioavailability and nasopharyngeal absorption of PMI-150 30mg.

Inclusion Criteria:

• Healthy adults

Exclusion Criteria:

• under 18 years